Effect of Anti-IgE in Chronic Urticaria
NCT00130234
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Urticaria
Interventions
DRUG:
Xolair® (Omalizumab)
Sponsor
Johns Hopkins University
Collaborators
[object Object]